Kuros Biosciences AG

Status: Publicly traded

Direct answer

Kuros Biosciences AG is publicly traded on SIX under the ticker KURN.SW.

Kuros Biosciences AG functions as a biopharmaceutical enterprise, dedicated to both the development and market introduction of advanced therapeutic solutions for tissue regeneration and bone repair. Its operations span across the United States, the European Union, and other global regions. The company's business activities are structured into three main segments: Medical Devices, Pharmaceuticals, and a Legacy...

Can you invest in Kuros Biosciences AG?

Yes. Kuros Biosciences AG is publicly traded on SIX under the ticker KURN.SW.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Kuros Biosciences AG

Detailed equity research is provided by MarketSnap.